Researchers have now developed EBOTAb, a pool of intact ovine immunoglobulin G, which has been shown to neutralize Ebola virus (EBOV) in vitro. The primary target was the highly glycosylated spike of EBOV (EBOV-GP1,2). A protein:adjuvant mixture was injected subcutaneously and equally into 6 …
2016
A novel immune mechanism of killing HIV infected cells
One of the most effective ways the immune system controls the spread of viral infection is through killing of infected cells. One strategy HIV uses to avoid infected cells from being killed by T cells
Protecting Mucosal immunity in HIV positive people with combined CCR5/Integrase Inhibitors
One of the pathologic events in HIV-infected individuals is the systemic inflammation caused by gut damage and translocation of microbial products into the circulation.
Solving the 50-year-old riddle: the link between Plasmodium falciparum Malaria and Endemic Burkitt’s Lymphoma
26th January, 2016
It has been conundrum for a long time: the link between endemic Burkitt’s lymphoma (eBL) with Plasmodium falciparum malaria infection
Why older people may succumb more readily to pneumonia
19th January, 2016
Age is known to be related to the levels of increased inflammatory cytokines in the blood and tissues. General inflammatory conditions
Does Chlamydia infection result in increased HIV susceptibility?
14th January, 2016
Chlamydia trachomatis is one of the most common sexually transmitted infections (STI) worldwide. In areas of high HIV transmission rates, especially in young females
A new theory to explain autoimmunity: The Altered Glycan Theory of Autoimmunity
4th January, 2016
All cells of the body are made of four classes of molecules: nucleic acids, proteins, lipids and glycans. Of the four, glycans have been least studied